Fibrinogen
Haematology marker
Fibrinogen
A clotting protein made by the liver that thrombin converts to fibrin, the structural mesh of a blood clot. It is also an acute-phase reactant and an independent cardiovascular risk marker.
PED Notes
Fibrinogen matters for enhanced athletes on two fronts. First, it is a clotting factor, so higher levels contribute to a more prothrombotic state, compounding the clot risk from androgen-driven erythrocytosis and high haematocrit. Second, it is an acute-phase protein that rises with inflammation, so heavy training, high body fat, and the low-grade inflammation seen on some cycles can push it up. A persistently high fibrinogen is an independent cardiovascular risk factor, which is directly relevant to the cardiovascular focus of harm reduction in PED users. No PED shifts the healthy target, so the bodybuilder range equals the standard range.
When high
When elevated (>4 g/L):
- High fibrinogen reflects inflammation, an acute-phase response, or a chronically prothrombotic/cardiovascular-risk profile.
- What to do:
- Ensure a rested, non-acute blood draw; recent hard training, infection, or injury transiently raises it.
- Address the cardiovascular-risk picture holistically: aerobic exercise, weight/body-fat reduction, smoking cessation, and omega-3 (EPA/DHA) 2-3g/day all help lower fibrinogen and overall clot risk.
- For AAS users, treat the dominant clot drivers in parallel: keep haematocrit in range and reconsider harsh oral compounds if the cardiovascular profile is worsening.
- A high fibrinogen alongside high CRP/ESR confirms an inflammatory contribution; investigate and treat the source.
When low
When low (<2 g/L):
- Low fibrinogen raises bleeding risk and points to reduced production or increased consumption: advanced liver disease (the liver makes fibrinogen), disseminated intravascular coagulation, or rare inherited deficiency.
- What to do: check liver function and a full coagulation panel. In an oral-AAS user, a low fibrinogen with abnormal liver enzymes and a prolonged PT is a red flag for failing hepatic synthesis; stop hepatotoxic orals and seek medical review promptly.
History Chart
Reading History
Frequently Asked Questions
Reference Ranges
Standard Range
VitalMetrics Range